loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-

    Client Email Product
    Menu

    5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 34,600Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 50629 / DOSAGE - INJECTABLE;INJECTION - 150MG/75ML

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DOXORUBICIN HYDROCHLORIDE(UNII: 82F2G7BL4E)
    (DOXORUBICIN - UNII:80168379AG)     		DOXORUBICIN HYDROCHLORIDE2mg in 1 | 2mg in 1 | 2mg in 1 | 2mg in 1 | 2mg in 1

    Inactive Ingredients

    Ingredient Name
    Pfizer Laboratories Div Pfizer Inc
    HYDROCHLORIC ACID(QTT17582CB)
    SODIUM CHLORIDE(451W47IQ8X)